IL7R and tuberculosis: In the future, the identified biomarkers could be applied to facilitate the development of effective assays for prediction of mortality in HIV + TB+ patients, the discovery of new drugs and vaccines that could restoring the gene expression of these genes (PTPRCv1, CD3E, CCL5, and IL7R), and aid monitoring of treatment responses.